Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
99.26
+0.83 (0.84%)
At close: Aug 8, 2025, 4:00 PM
99.00
-0.26 (-0.26%)
After-hours: Aug 8, 2025, 7:05 PM EDT
Zimmer Biomet Holdings Employees
Zimmer Biomet Holdings had 17,000 employees as of December 31, 2024. The number of employees decreased by 1,000 or -5.56% compared to the previous year.
Employees
17,000
Change (1Y)
-1,000
Growth (1Y)
-5.56%
Revenue / Employee
$460,812
Profits / Employee
$48,441
Market Cap
19.66B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17,000 | -1,000 | -5.56% |
Dec 31, 2023 | 18,000 | 0 | - |
Dec 31, 2022 | 18,000 | -1,500 | -7.69% |
Dec 31, 2021 | 19,500 | -500 | -2.50% |
Dec 31, 2020 | 20,000 | 100 | 0.50% |
Dec 31, 2019 | 19,900 | 900 | 4.74% |
Dec 31, 2018 | 19,000 | 800 | 4.40% |
Dec 31, 2017 | 18,200 | -300 | -1.62% |
Dec 31, 2016 | 18,500 | 1,000 | 5.71% |
Dec 31, 2015 | 17,500 | 7,500 | 75.00% |
Dec 31, 2014 | 10,000 | 500 | 5.26% |
Dec 31, 2013 | 9,500 | 200 | 2.15% |
Dec 31, 2012 | 9,300 | 600 | 6.90% |
Dec 31, 2011 | 8,700 | -100 | -1.14% |
Dec 31, 2010 | 8,800 | 600 | 7.32% |
Dec 31, 2009 | 8,200 | -300 | -3.53% |
Dec 31, 2008 | 8,500 | 900 | 11.84% |
Dec 31, 2007 | 7,600 | 700 | 10.14% |
Dec 31, 2006 | 6,900 | 200 | 2.99% |
Dec 31, 2005 | 6,700 | 100 | 1.52% |
Dec 31, 2004 | 6,600 | 100 | 1.54% |
Dec 31, 2003 | 6,500 | 2,900 | 80.56% |
Dec 31, 2002 | 3,600 | 200 | 5.88% |
Dec 31, 2001 | 3,400 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ZBH News
- 1 day ago - Zimmer Biomet Holdings, Inc. (ZBH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook - Benzinga
- 1 day ago - Zimmer Biomet raises annual profit forecast on strong demand for medical devices - Reuters
- 18 days ago - Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA - Seeking Alpha
- 23 days ago - MONOGRAM TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Monogram Technologies Inc. - MGRM - Business Wire
- 4 weeks ago - Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025 - PRNewsWire
- 2 months ago - Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas - PRNewsWire